In a study looking at glioblastoma, Shnaper S et al. have shown that elevated levels of GDF15 in the CSF is associated with worse patient outcomes indicating that our findings in patient plasma needs to be contrasted with CSF GDF15 levels42. This evidence concerns the gene GDF15 and glioblastoma.